CBS 2019
CBSMD教育中心
English

二尖瓣/三尖瓣瓣膜

科研文章

荐读文献

Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation: Outcomes at 2 years Closure of Iatrogenic Atrial Septal Defect Following Transcatheter Mitral Valve Repair: The Randomized MITHRAS Trial Association Between Malignant Mitral Valve Prolapse and Sudden Cardiac Death: A Review Initial experience with percutaneous mitral valve repair in patients with cardiac amyloidosis The Tricuspid Annular Plane Systolic Excursion to Systolic Pulmonary Artery Pressure Index: Association With All-Cause Mortality in Patients With Moderate or Severe Tricuspid Regurgitation Patient and Hospital Characteristics of Mitral Valve Surgery in the United States Thrombotic Risk and Antithrombotic Strategies After Transcatheter Mitral Valve Replacement Italian Society of Interventional Cardiology (GIse) Registry Of Transcatheter Treatment of Mitral Valve RegurgitaTiOn (GIOTTO): Impact of Valve Disease Etiology and Residual Mitral Regurgitation after MitraClip Implantation Transcatheter Interventions for Tricuspid Valve Disease: What to Do and Who to Do it On Transcatheter Interventions for Mitral Regurgitation: Multimodality Imaging for Patient Selection and Procedural Guidance
|<< 1 2 3 4 >>|

Clinical TrialNov 06, 2021.

JOURNAL:J Am Coll Cardiol Intv. Article Link

Thirty-Day Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement: Intrepid TMVR Early Feasibility Study Results

F Zahr , HK Song , SM Chadderdon et al. Keywords: TMVR; early feasibility study; 30-day outcome

Full Text PDF